Effect of the exposure to brominated flame retardants on hyperuricemia using interpretable machine learning algorithms based on the SHAP methodology
- PMID: 40570004
- PMCID: PMC12200863
- DOI: 10.1371/journal.pone.0325896
Effect of the exposure to brominated flame retardants on hyperuricemia using interpretable machine learning algorithms based on the SHAP methodology
Abstract
Background: Brominated flame retardants (BFRs) are classified as important endocrine disruptors and persistent organic pollutants; nevertheless, there is no comprehensive investigation to evaluate the association between BFRs and hyperuricemia, and the available studies related to this field are exceptionally scarce.
Methods: For this study, we enrolled 3,812 individuals from NHANES 2005-2016, with nine different types of BFRs serving as the exposure. We conducted advanced machine learning techniques, along with regression analysis to validate our findings from diverse perspectives. Weighted logistic regression were employed to evaluate the association of BFRs for both continuous variables after logarithmic transformation and their quartile subgroups with hyperuricemia. Restricted cubic spline (RCS) analysis was conducted to identify whether a non-linear relationship exists. Subgroup analysis enabled us to explore potential interactions of research findings across different groups. Weighted quantile sum (WQS) regression was performed to assess collective mixture sum impact, along with contributions of each component. Nine machine-learning models were developed for hyperuricemia prediction, and six discrimination characteristics were applied to select the optimal model. SHapley Additive exPlanations (SHAP) was utilized to interpret the contributions of selected variables for model decision-making capacity.
Results: Several BFRs exhibited noticeable positive correlation with the prevalence of hyperuricemia, including PBDE28 (OR: 1.27, 95% CI: 1.05-1.54, P-value = 0.014), PBDE47 (OR: 1.19, 95% CI: 1.02-1.40, P-value = 0.032), PBDE85 (OR: 1.16, 95% CI: 1.01-1.34, P-value = 0.036), PBDE99 (OR: 1.17, 95% CI: 1.02-1.34, P-value = 0.025), and PBDE154 (OR: 1.16, 95% CI: 1.00-1.34, P-value = 0.050) after fully adjustment. The WQS analysis found that the sum effect of BFRs was positively associated with hyperuricemia, of which PBDE28 (28.70%), PBDE85 (22.10%) and PBDE47 (14.90%) were the top 3 components. XGboost exhibited superior performance across several important metrics. The SHAP analysis revealed that the PBDE85, PBDE28 and PBDE154 exhibited considerable influence, ranking after "BMI≥30", "Race-Non-Hispanic Black" and "Hypertension-Yes".
Conclusions: Combining the outcomes, our study identified PBDE28 and PBDE85 as the two major significant contributors to elevated prevalence of hyperuricemia. Other components, such as PBDE154, PBDE47, PBDE99, and PBDE100, emerged as potential pollutants. These pioneering efforts highlighted the previously underrecognized impact on this environmental and public health concern.
Copyright: © 2025 Cai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures







Similar articles
-
Association between brominated flame retardants and heart failure in U.S. adults: A cross-sectional analysis of national health and nutrition examination survey 2005-2016.Heart Lung. 2025 May-Jun;71:47-55. doi: 10.1016/j.hrtlng.2025.02.004. Epub 2025 Feb 24. Heart Lung. 2025. PMID: 39999515
-
Identifying emphysema risk using brominated flame retardants exposure: a machine learning predictive model based on the SHAP methodology.Front Public Health. 2025 Jun 25;13:1600729. doi: 10.3389/fpubh.2025.1600729. eCollection 2025. Front Public Health. 2025. PMID: 40636877 Free PMC article.
-
Analysis of brominated flame retardants exposure-associated chronic kidney disease risk in the US population from the NHANES.Ecotoxicol Environ Saf. 2024 Nov 1;286:117159. doi: 10.1016/j.ecoenv.2024.117159. Epub 2024 Oct 8. Ecotoxicol Environ Saf. 2024. PMID: 39383822
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources